Matrix metalloproteinases and clinical and functional status in smokers with persistent asthma

Matrix metalloproteinases and clinical and functional status in smokers with persistent asthma

AIM. To assess the role of matrix metalloproteinases (MMP) in the clinical and functional status of smoking patients with persistent asthma. MATERIALS AND METHODS. Examinations were made in 16 healthy smokers (a control group), 22 healthy nonsmoking volunteers (a volunteer group), and 16 patients wi...

Full description

Bibliographic Details
Main Authors:	V V Gnoevykh, T P Gening, Iu A Portnova, T V Abakumova, A Iu Smirnova, D R Dolgova
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2014-08-01
Series:	Терапевтический архив
Subjects:	matrix metalloproteinases asthma blood oxygenation airway inflammation
Online Access:	https://ter-arkhiv.ru/0040-3660/article/view/31539

Similar Items

The risk of bronchial asthma exacerbations among smokers with asthma-chronic obstructive pulmonary disease overlap after inpatient treatment
by: V. V. Gnoevykh, et al.
Published: (2020-03-01)

The content of matrix metalloproteinase-1, -9 and tissue inhibitor of matrix metalloproteinase-1 in patients with bronchial asthma and obesity
by: V. V. Kachkovska, et al.
Published: (2023-12-01)

MATRIX METALLOPROTEINASES AS MARKERS OF RESPIRATORY TRACT REMODELING AND POTENTIAL THERAPEUTIC TARGET IN PATIENTS WITH BRONCHIAL ASTHMA
by: Vladyslava V. Kachkovska
Published: (2021-06-01)

Asthma remodeling: The pathogenic role of matrix metalloproteinase-9
by: Amgad A. Farhat, et al.
Published: (2014-10-01)

Role of Matrix Metalloproteinase-2 in Eosinophil-Mediated Airway Remodeling
by: Yu Kuwabara, et al.
Published: (2018-09-01)

Genetic polymorphisms of matrix metalloproteinase-9, tissue inhibitor of matrix metalloproteinase-1 and development of postoperative atrial fibrillation in elderly patients
by: A. O. Rubanenko, et al.
Published: (2018-11-01)

Evaluation of matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 levels in bronchoalveolar lavage of apparently healthy smokers
by: Ali M. Abdella, et al.
Published: (2015-04-01)

Protective Role of Matrix Metalloproteinase-2 in Allergic Bronchial Asthma
by: Yoshinori Takahashi, et al.
Published: (2019-08-01)

ASSOCIATION OF MATRIX METALLOPROTEINASES GENE POLYMORPHISM WITH CLINICAL MANIFESTATIONS OF BRONCHIAL ASTHMA IN CHILDREN
by: A. A. Lebedenko, et al.
Published: (2018-12-01)

MATRIX METALLOPROTEINASES AND TISSUE INHIBITORS OF MATRIX METALLOPROTEINASES DURING PREGNANCY AND DELIVERY
by: Yu. V. Korenovsky, et al.
Published: (2012-09-01)

Polymerizable Matrix Metalloproteinases’ Inhibitors with Potential Application for Dental Restorations
by: Helena Laronha, et al.
Published: (2021-03-01)

Matrix metalloproteinases-9 and tissue inhibitor of matrix metalloproteinases-1 in sarcoidosis patients
by: Ivanišević Jasmina, et al.
Published: (2017-01-01)

CTGF upregulation correlates with MMP-9 level in airway remodeling in a murine model of asthma
by: Sheng-Chieh Lin, et al.
Published: (2016-06-01)

The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases
by: Griselda A Cabral-Pacheco, et al.
Published: (2020-12-01)

Comparative characteristic of methods for determining the inflammation marker matrix metalloproteinase-9
by: E. V. Baranova, et al.
Published: (2014-12-01)

The Role of Matrix Metalloproteinases in Colorectal Cancer
by: Anan H. Said, et al.
Published: (2014-02-01)

Expression of matrix metalloproteinase-2 and 9 with their inhibitors, tissue inhibitors of metalloproteinase-1 and 2 in oral lichen planus
by: Natheer Hashim Al-Rawi, et al.
Published: (2014-01-01)

Perioceutics: Matrix metalloproteinase inhibitors as an adjunctive therapy for inflammatory periodontal disease
by: Esther Nalini Honibald, et al.
Published: (2012-01-01)

Matrix Metalloproteinases in Health and Disease
by: Raffaele Serra
Published: (2020-08-01)

The role of matrix metalloproteinases in early and late gonarthrosis manifestations
by: Ekaterina V. Gladkova
Published: (2020-09-01)

The role of matrix metalloproteinase-2 and miR-196a2 in bronchial asthma pathogenesis and diagnosis
by: Osama A. Mohammed, et al.
Published: (2024-03-01)

Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Echinoderms: Structure and Possible Functions
by: Igor Yu. Dolmatov, et al.
Published: (2021-09-01)

Structure and Function of Human Matrix Metalloproteinases
by: Helena Laronha, et al.
Published: (2020-04-01)

Significance of matrix metalloproteinases and their ihhibitors in normal subjects, solid and blood cancer patients
by: Nadezhda Vladimirovna Gaydamaka, et al.
Published: (2009-07-01)

Matrix Metalloproteinases/Tissue Inhibitors of Metalloproteinases Ratio: A Biomarker of Bone Resorption in Geriatric Osteoporosis?
by: Bahar Bektan Kanat, et al.
Published: (2023-06-01)

Matrix metalloproteinases, inhibitor of metalloproteinases mRNA and protein expression in laryngeal squamous cell carcinoma
by: Weronika Lucas Grzelczyk, et al.
Published: (2019-04-01)

Role of Matrix Metalloproteinases in Musculoskeletal Diseases
by: Lokender Kumar, et al.
Published: (2022-10-01)

ELISA study of matrix metalloproteinases 2, 7, 9 and their type 2 tissue inhibitor in the tumors of gastric cancer patients: clinical and pathologic correlations
by: E. S. Gershtein, et al.
Published: (2018-09-01)

Matrix metalloproteinase-2 (MMP-2), MMP-9, tissue inhibitor of matrix metalloproteinases (TIMP-1) and transforming growth factor-β2 (TGF-β2) expression in eutopic endometrium of women with peritoneal endometriosis
by: Krzysztof Szymanowski, et al.
Published: (2016-09-01)

Challenges in Matrix Metalloproteinases Inhibition
by: Helena Laronha, et al.
Published: (2020-05-01)

Complex studies on gene polymorphisms of MMP2, MMP3, MMP9 matrix metalloproteinases and TIMP1, TIMP2 tissue inhibitors of metalloproteinases in the patients with primary open-angle glaucoma
by: A. V. Shevchenko, et al.
Published: (2023-04-01)

Expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 in recurrent chronic rhinosinusitis with nasal polyposis
by: Ling-Feng Wang, et al.
Published: (2013-01-01)

Matrix metalloproteinase 2, 3, and 9 gene polymorphisms in women with rheumatoid arthritis
by: A V Shevchenko, et al.
Published: (2015-12-01)

Matrix metalloproteinase-9, its inhibitor-1 and interleukines in experimental traumatic brain injury
by: S. V. Ziablitsev, et al.
Published: (2016-12-01)

The Versatile Role of Matrix Metalloproteinase for the Diverse Results of Fibrosis Treatment
by: Hong-Meng Chuang, et al.
Published: (2019-11-01)

Quercetin prevent proteoglycan destruction by inhibits matrix metalloproteinase-9, matrix metalloproteinase-13, a disintegrin and metalloproteinase with thrombospondin motifs-5 expressions on osteoarthritis model rats
by: Dian Agustina Permatasari, et al.
Published: (2019-01-01)

Matrix metalloproteinases and their tissue inhibitors as novel markers in invasive pituitary adenomas – a review
by: Joanna Szydełko, et al.
Published: (2019-09-01)

Matrix metalloproteinases and their tissue inhibitors as novel markers in invasive pituitary adenomas – a review
by: Joanna Szydełko, et al.
Published: (2019-09-01)

Comparative analysis of content of the matrix metalloproteinase-9 in patients with acute cerebral strokes of different types
by: E. V. Baranova
Published: (2014-10-01)

Role of matrix metalloproteinases in the pathophysiology of idiopathic pulmonary fibrosis
by: Bhattacharyya P, et al.
Published: (2007-01-01)